Carl Byrnes
Stock Analyst at Northland Capital Markets
(1.59)
# 2,235
Out of 4,413 analysts
14
Total ratings
50%
Success rate
15.99%
Average return
Main Sectors:
9 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COCH Envoy Medical | Initiates: Outperform | n/a | $4.25 | - | 1 | Dec 21, 2023 | |
| AMRN Amarin Corporation | Maintains: Market Perform | $2 → $1.25 | $0.92 | +35.74% | 1 | Jul 19, 2023 | |
| CDIO Cardio Diagnostics Holdings | Initiates: Outperform | $8 | $0.69 | +1,067.88% | 1 | May 22, 2023 | |
| BWAY BrainsWay | Maintains: Outperform | $15 → $5 | $5.25 | -4.76% | 1 | Nov 17, 2022 | |
| VTVT vTv Therapeutics | Maintains: Outperform | $60 → $80 | $27.90 | +186.74% | 3 | Aug 17, 2022 | |
| MDXG MiMedx Group | Initiates: Outperform | n/a | $6.16 | - | 1 | Jul 26, 2021 | |
| ESPR Esperion Therapeutics | Maintains: Market Perform | n/a | $1.97 | - | 4 | May 5, 2021 | |
| AYTU Aytu BioPharma | Initiates: Outperform | n/a | $2.81 | - | 1 | Oct 22, 2018 | |
| HRTX Heron Therapeutics | Initiates: Outperform | n/a | $2.32 | - | 1 | Sep 27, 2017 |
Envoy Medical
Dec 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $4.25
Upside: -
Amarin Corporation
Jul 19, 2023
Maintains: Market Perform
Price Target: $2 → $1.25
Current: $0.92
Upside: +35.74%
Cardio Diagnostics Holdings
May 22, 2023
Initiates: Outperform
Price Target: $8
Current: $0.69
Upside: +1,067.88%
BrainsWay
Nov 17, 2022
Maintains: Outperform
Price Target: $15 → $5
Current: $5.25
Upside: -4.76%
vTv Therapeutics
Aug 17, 2022
Maintains: Outperform
Price Target: $60 → $80
Current: $27.90
Upside: +186.74%
MiMedx Group
Jul 26, 2021
Initiates: Outperform
Price Target: n/a
Current: $6.16
Upside: -
Esperion Therapeutics
May 5, 2021
Maintains: Market Perform
Price Target: n/a
Current: $1.97
Upside: -
Aytu BioPharma
Oct 22, 2018
Initiates: Outperform
Price Target: n/a
Current: $2.81
Upside: -
Heron Therapeutics
Sep 27, 2017
Initiates: Outperform
Price Target: n/a
Current: $2.32
Upside: -